| Steve Scott, MD | |
|
1919 S Wheeling Ave, Suite 500, Tulsa, OK 74104-5638 | |
| (918) 748-7650 | |
| (918) 293-3147 |
| Full Name | Steve Scott |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1919 S Wheeling Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962427997 | NPI | - | NPPES |
| 100119650A | Medicaid | OK | |
| P00295067 | Other | OK | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 19020 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steve Scott, MD 1515 N Harvard Ave, Suite E, Tulsa, OK 74115-4957 Ph: (918) 832-6049 | Steve Scott, MD 1919 S Wheeling Ave, Suite 500, Tulsa, OK 74104-5638 Ph: (918) 748-7650 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).
A study by York University researcher Caroline Davis and her colleagues at the Centre for Addiction and Mental Health is the first to demonstrate that variants of the Oxytocin Receptor gene contribute to why some of us overeat or engage in episodes of binge eating.
Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) reduce side effects from corticosteroid-based creams used to treat certain skin diseases.
Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.
A University of Ottawa-led study of nearly 250,000 children in Ontario over seven years – the largest of its kind – found a mother's weight before pregnancy may impact their newborn's risk of developing allergic diseases in early childhood, whereas weight gain during pregnancy did not seem to have the same effect.
› Verified 8 days ago
Sarah Anne Shaw-dressler, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave Ste 100a, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Julia Margaret Kwon, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1705 E 19th St Ste 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Peter Madden, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-619-4400 | |
Thao Tran, D.O Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4502 E. 41st Street, Tulsa, OK 74135 Phone: 918-619-4400 | |
Robert Peter Aran, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6160 S Yale Ave Ste 100, Tulsa, OK 74136 Phone: 918-497-3300 Fax: 918-497-3365 | |
Robert Dean Okada, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave, Ste 304, Tulsa, OK 74136 Phone: 918-494-5300 Fax: 918-494-5455 | |
Dr. Charles Wade Taylor, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 Fax: 918-505-3253 |